The U.S. Environmental Protectional Agency has proposed strict new limits on six types of per- and polyfluoroalkyl substances (PFAS) in drinking water. Public health experts are positive about the move but say that, ultimately, all types of these toxic chemicals—there are thousands in use—need to be regulated.
Nearly half of all employees in state and local public health agencies in the U.S. left their jobs between 2017 and 2021, and if such workforce contractions continue, more than 100,000 public health staff could leave their jobs by 2025, according to a new study from Harvard Chan School.
Pharmaceutical company Eli Lilly’s recent decision to cut costs for its most popular insulin products was a positive move, but more work is needed to make overall diabetes care more affordable, particularly for the uninsured, according to Harvard Chan School’s Anna Sinaiko.
Patients insured by Medicare Advantage had fewer hospitalizations for potentially avoidable conditions compared to patients insured by traditional Medicare, according to a new study.
India is not on target to reach more than half of the United Nations’ Sustainable Development Goals (SDGs)—a broad set of global goals set in 2015 by UN member states—by the organization’s 2030 deadline, according to a study led by Harvard Chan School.
Childhood obesity rates tripled in the U.S. over the past 30 years, and further surged during theCOVID-19 pandemic.
Urban development is limiting people’s exposure to nature, potentially leading them to develop biophobia, or a fear of nature, according to experts. The fear could have consequences for the environment, since individuals who fear nature may be less likely to support conservation efforts.
A range of topics regarding health care in Africa—including mental health, malaria, financing, and vaccine research, development, and manufacturing—were examined at the first-ever Africa Health Conference at Harvard Chan School.
Recent changes to Chinese health insurance sparked protests by hundreds of older people in two cities, but the changes could make the health care system more equitable, according to Harvard Chan School experts.
Publicly, the tobacco industry endorses harm reduction—a strategy aimed at reducing risks for people who use their products. But the reality, according to an opinion piece in STAT, is that the industry continues to oppose policies aimed at curbing cigarette use while promoting vaping, from which it stands to reap huge profits.
